In the present study, we demonstrated that FEV was re-expressed in 30% of primary and in almost all relapsed AML samples with high expression levels, and we found that FEV maintains the homing and expansion abilities of AML cells by directly activating integrin subunit alpha 4 (ITGA4) transcription. The gene discussed is FEV; the disease is acute myeloid leukemia.